FSA Wealth Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-398	Closed	-$26K	–	413
2019 Q4	$26K	Buy	+398	New	+$26K	0.02%	197